Your session is about to expire
← Back to Search
Stromal Vascular Fraction
GID SVF-2 for Erectile Dysfunction
N/A
Waitlist Available
Research Sponsored by GID BIO, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights
Study Summary
This trial will test if a single injection of a person's own fat cells can improve erectile dysfunction.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Adverse Events
Secondary outcome measures
International Index of Erectile Function (IIEF)
Other outcome measures
Partner Satisfaction Questionnaire
Trial Design
1Treatment groups
Experimental Treatment
Group I: TreatmentExperimental Treatment1 Intervention
Each subject will receive a single injection of autologous adipose-derived stromal vascular fraction (SVF) and will be monitored for 6 months
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GID SVF-2
2016
N/A
~50
Find a Location
Who is running the clinical trial?
GID BIO, Inc.Lead Sponsor
4 Previous Clinical Trials
180 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
Tennessee
North Carolina
How old are they?
18 - 65
What site did they apply to?
David Matthews MD
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
Recent research and studies
Share this study with friends
Copy Link
Messenger